- 611 Downloads
Physiological aging is universal, intrinsic, and progressive. It is an inevitable, preprogramed progression and fundamentally difficult to treat, recover from, or prevent. Many longevity genes have been discovered, from those in nematodes to those in mice. Remarkable results have been achieved in the development of longevity in living organisms using molecular biological techniques and disease research from a cellular aging level.
Pathological aging occurs in the elderly and has almost the same definition as geriatric syndrome. It has various causes and nursing care is required during treatment. In Western countries, it is called the “Geriatric Giant” due to this care requirement.
Geriatric diseases reduce life span and declined functional residual capacity in the elderly. Cerebrovascular attack (CVA) and ischemic heart disease (IHD) both fall into this category. Cellular aging, the basic subunit of physiological aging, undergoes dynamic changes in pathological conditions and may be an important onset factor for geriatric disease. We discuss the effects of aging on cardiovascular disease from these viewpoints.
Aging is one of independent cardiovascular risks. Recent advances in research are revealing the detailed mechanisms of the effect of aging in the human cardiovascular disease. Some effects of aging are different on people and we are also able to regulate the effects partially. Dividing the status of patients into physiological aging, pathological aging = geriatric syndrome, and disease may help the approach described as above.
KeywordsLate elderly Physiological aging Geriatric syndrome Geriatric disease Cellular aging
- Abridged Life Tables for Japan (2010) By Statistics and Information Department Minister’s Secretariat Ministry of Health, Labour and Welfare Japanese Government. Available at http://www.mhlw.go.jp/english/database/db-hw/lifetb10/index.html
- Declining Birth Rate and Aging Population by Statistics Bureau, Director-General for Policy Planning (Statistical Standards and Statistical Research and Training Institute). Available at http://www.stat.go.jp/english/data/handbook/c02cont.htm
- Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, Kamalanathan S, Hattori Y, Ignarro LJ, Iguchi A (2006) Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci U S A 103:17018–23PubMedCrossRefGoogle Scholar
- Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H, Hattori Y, Ohrui T, Yoshizumi M, Yokote K, Kubota K, Nomura H, Umegaki H, Iguchi A, ; Japan CDM group (2008b) Importance of lipid levels in elderly diabetic individuals: baseline characteristics and 1-year survey of cardiovascular events. Circ J 72:218–25PubMedCrossRefGoogle Scholar
- Hayashi T, Kawashima S, Itoh H, Yamada N, Sone H, Watanabe H, Hattori Y, Ohrui T, Yokote K, Nomura H, Umegaki H, Iguchi A, ; Japan CDM Group (2009) Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages. Diabetes Care 32:1221–3PubMedCrossRefGoogle Scholar
- Hayashi T, Maeda M, Ina K, Matsui-Hirai H, Iguchi A (2010) The diverse role of insulin on endothelial senescence - the difference of continuous and intermittent high glucose. Nitric Oxide Biol Chem 22:S94–S95Google Scholar
- Hayashi T, Kawashima S, Nomura H, Itoh H, Watanabe H, Ohrui T, Yokote K, Sone H, Hattori Y, Yoshizumi M, Ina K, Kubota K, ; Japan Cholesterol and Diabetes Mellitus Investigation Group (2011) Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovasc Diabetol 10:86–91PubMedCrossRefGoogle Scholar
- Hayashi T, Araki A, Kawashima S, Sone H, Watanabe H, Ohrui T, Yokote K, Takemoto M, Kubota K, Noda M, Noto H, Ina K, Nomura H (2013) Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age. Cardiovasc Diabetol 12:10–6PubMedCrossRefGoogle Scholar
- Isaacs B (1992) The challenge of geriatric medicine. Oxford University Press, LondonGoogle Scholar
- JAPAN Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases (2007) Edition available at http://www.j-athero.org/en/publications/guideline2007.html
- Miyazaki-Akita A, Hayashi T, Ding QF, Shiraishi H, Nomura T, Hattori Y, Iguchi A (2007) 17beta-estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease. J Pharmacol Exp Ther 320:591–8PubMedCrossRefGoogle Scholar
- Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Uchiyama S, Nakamura H, ; MEGA Study Group (2008) Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study). Circulation 117:494–502PubMedCrossRefGoogle Scholar
- Sekimoto H, Goto Y, Goto Y, Naito C, Yasugi T, Okido M, Kuzuya F, Takeda R, Yamamoto A, Fukuzaki H et al (1983) Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Research committee on familial hyperlipidemia in Japan. Jpn Circ J 47:1351–8PubMedCrossRefGoogle Scholar
- Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O”Brien E, Ostergren J, ASCOT investigators (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled tria. Lancet 361:1149–58PubMedCrossRefGoogle Scholar
- Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, PROSPER Study Group (2002) PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER). Lancet 360:1623–30PubMedCrossRefGoogle Scholar
- Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, ; Japan EPA lipid intervention study (JELIS) Investigators (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090–8PubMedCrossRefGoogle Scholar